Montaner LJ - Search Results

1

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.

Papasavvas E, Grant RM, Sun J, Mackiewicz A, Pistilli M, Gallo C, Kostman JR, Mounzer K, Shull J, Montaner LJ. Papasavvas E, et al. Among authors: montaner lj. AIDS. 2003 Nov 7;17(16):2337-43. doi: 10.1097/00002030-200311070-00008. AIDS. 2003. PMID: 14571185

2

IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression.

Bailer RT, Holloway A, Sun J, Margolick JB, Martin M, Kostman J, Montaner LJ. Bailer RT, et al. Among authors: montaner lj. J Immunol. 1999 Jun 15;162(12):7534-42. J Immunol. 1999. PMID: 10358209

3

The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals.

Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, Trinchieri G. Marshall JD, et al. Among authors: montaner lj. Blood. 1999 Aug 1;94(3):1003-11. Blood. 1999. PMID: 10419892 Free article.

4

Inhibition of IL-12 production in human monocyte-derived macrophages by TNF.

Ma X, Sun J, Papasavvas E, Riemann H, Robertson S, Marshall J, Bailer RT, Moore A, Donnelly RP, Trinchieri G, Montaner LJ. Ma X, et al. Among authors: montaner lj. J Immunol. 2000 Feb 15;164(4):1722-9. doi: 10.4049/jimmunol.164.4.1722. J Immunol. 2000. PMID: 10657616

5

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption.

Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, Moonis M, Sandberg JK, Drohan LA, Gallagher B, Shull J, Nixon DF, Kostman JR, Montaner LJ. Papasavvas E, et al. Among authors: montaner lj. J Infect Dis. 2000 Sep;182(3):766-75. doi: 10.1086/315748. Epub 2000 Aug 17. J Infect Dis. 2000. PMID: 10950770 Clinical Trial.

6

HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.

Muthumani K, Kudchodkar S, Papasavvas E, Montaner LJ, Weiner DB, Ayyavoo V. Muthumani K, et al. Among authors: montaner lj. J Leukoc Biol. 2000 Sep;68(3):366-72. J Leukoc Biol. 2000. PMID: 10985253

7

Structured treatment interruptions to control HIV-1 and limit drug exposure.

Montaner LJ. Montaner LJ. Trends Immunol. 2001 Feb;22(2):92-6. doi: 10.1016/s1471-4906(00)01809-3. Trends Immunol. 2001. PMID: 11286710 Review.

8

IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness.

Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, Mackiewicz A, Montaner LJ, Trinchieri G, Karp CL. Wysocka M, et al. Among authors: montaner lj. J Immunol. 2001 Jun 15;166(12):7504-13. doi: 10.4049/jimmunol.166.12.7504. J Immunol. 2001. PMID: 11390504

9

CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.

Moonis M, Lee B, Bailer RT, Luo Q, Montaner LJ. Moonis M, et al. Among authors: montaner lj. AIDS. 2001 Oct 19;15(15):1941-9. doi: 10.1097/00002030-200110190-00005. AIDS. 2001. PMID: 11600821

10

Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.

Chehimi J, Campbell DE, Azzoni L, Bacheller D, Papasavvas E, Jerandi G, Mounzer K, Kostman J, Trinchieri G, Montaner LJ. Chehimi J, et al. Among authors: montaner lj. J Immunol. 2002 May 1;168(9):4796-801. doi: 10.4049/jimmunol.168.9.4796. J Immunol. 2002. PMID: 11971031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters